Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Nutrien Ltd. (NTR) Stock Forecast & Price Prediction Canada | NYSE | Basic Materials | Agricultural Inputs
$66.13
-1.49 (-2.20%)Did NTR Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Nutrien is one of their latest high-conviction picks.
Based on our analysis of 6 Wall Street analysts, NTR has a bullish consensus with a median price target of $82.50 (ranging from $65.00 to $96.00). The overall analyst rating is Buy (7.8/10). Currently trading at $66.13, the median forecast implies a 24.8% upside. This outlook is supported by 16 Buy, 6 Hold, and 2 Sell ratings.
Conversely, the most conservative target is provided by Lucas Beaumont at UBS, suggesting a 1.7% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for NTR.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 12, 2026 | Oppenheimer | Kristen Owen | Outperform | Maintains | $82.00 |
| May 11, 2026 | UBS | Lucas Beaumont | Sell | Maintains | $65.00 |
| May 11, 2026 | JP Morgan | Jeffrey Zekauskas | Overweight | Maintains | $80.00 |
| May 11, 2026 | Scotiabank | Ben Isaacson | Sector Perform | Maintains | $80.00 |
| Apr 30, 2026 | CIBC | Outperformer | Maintains | $N/A | |
| Apr 27, 2026 | Barclays | Overweight | Upgrade | $N/A | |
| Apr 22, 2026 | Oppenheimer | Outperform | Maintains | $N/A | |
| Apr 20, 2026 | Scotiabank | Sector Perform | Maintains | $N/A | |
| Apr 8, 2026 | Morgan Stanley | Overweight | Maintains | $N/A | |
| Mar 26, 2026 | UBS | Sell | Downgrade | $N/A | |
| Mar 18, 2026 | B of A Securities | Neutral | Maintains | $N/A | |
| Mar 18, 2026 | BMO Capital | Outperform | Maintains | $N/A | |
| Mar 17, 2026 | CIBC | Outperformer | Maintains | $N/A | |
| Mar 13, 2026 | Wells Fargo | Overweight | Upgrade | $N/A | |
| Mar 12, 2026 | Jefferies | Buy | Upgrade | $N/A | |
| Mar 3, 2026 | Barclays | Equal-Weight | Maintains | $N/A | |
| Feb 26, 2026 | Oppenheimer | Outperform | Maintains | $N/A | |
| Feb 23, 2026 | Jefferies | Hold | Maintains | $N/A | |
| Feb 23, 2026 | RBC Capital | Outperform | Maintains | $N/A | |
| Feb 20, 2026 | JP Morgan | Overweight | Maintains | $N/A |
The following stocks are similar to Nutrien based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Nutrien Ltd. has a market capitalization of $31.74B with a P/E ratio of 13.8x. The company generates $26.88B in trailing twelve-month revenue with a 8.9% profit margin.
Revenue growth is +19.0% quarter-over-quarter, while maintaining an operating margin of +6.5% and return on equity of +9.8%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Provides essential crop inputs and agricultural services.
The company operates through four segments: Nutrien Ag Solutions, Potash, Nitrogen, and Phosphate. It generates revenue by distributing crop nutrients, seeds, and protection products, alongside offering various services such as soil testing and precision agriculture technologies to farmers worldwide.
Founded in 2018 and based in Saskatoon, Saskatchewan, Nutrien Ltd. is integral to the agricultural supply chain, enhancing farming practices and promoting sustainable nutrient management. It serves a global clientele, including growers, retailers, and agribusinesses, through a robust production and distribution network.
Basic Materials
Agricultural Inputs
25,500
Mr. Kenneth A. Seitz
Canada
2007
Nutrien (NTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Nutrien Ltd. (NTR) received an unsolicited mini-tender offer from Ocehan LLC to buy 100,000 shares at C$70.20 each, a discount of about 25% from recent closing prices.
Ocehan's unsolicited mini-tender offer at a significant discount may signal undervaluation concerns and could impact Nutrien's stock price and investor sentiment.
Zacks Style Scores help investors identify top-rated stocks tailored to their investing style, presenting a valuable tool for stock selection.
Zacks Style Scores can help investors quickly identify high-potential stocks aligned with their strategies, enhancing decision-making and potentially improving returns.
Nutrien (NTR) reported earnings 30 days ago; investors may be looking for upcoming developments or trends affecting the stock's performance.
Nutrien's earnings report may influence stock performance and investor sentiment, impacting future valuations and strategies in the agricultural sector.
Nutrien reports strong earnings momentum driven by high fertilizer demand, rising prices, and effective cost cuts, with record potash volumes contributing significantly.
Nutrien's strong performance reflects robust fertilizer demand and rising prices, indicating potential for increased profitability and positive market sentiment.
NTR benefits from high fertilizer demand, rising prices, and cost reductions; however, volatile input costs and supply constraints may pressure margins.
NTR's strong performance from fertilizer demand and cost cuts boosts growth prospects, but input cost volatility and supply issues could pressure future margins, impacting profitability.
NTR has priced $1B in senior notes due 2031 and 2036 to refinance debt, enhance liquidity, and support working capital requirements.
NTR's $1B senior notes issuance enhances liquidity and reduces debt pressure, improving financial stability and potentially boosting credit ratings, which can positively affect stock performance.
Based on our analysis of 6 Wall Street analysts, Nutrien Ltd. (NTR) has a median price target of $82.50. The highest price target is $96.00 and the lowest is $65.00.
According to current analyst ratings, NTR has 16 Buy ratings, 6 Hold ratings, and 2 Sell ratings. The stock is currently trading at $66.13. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict NTR stock could reach $82.50 in the next 12 months. This represents a 24.8% increase from the current price of $66.13. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company operates through four segments: Nutrien Ag Solutions, Potash, Nitrogen, and Phosphate. It generates revenue by distributing crop nutrients, seeds, and protection products, alongside offering various services such as soil testing and precision agriculture technologies to farmers worldwide.
The highest price target for NTR is $96.00 from at , which represents a 45.2% increase from the current price of $66.13.
The lowest price target for NTR is $65.00 from Lucas Beaumont at UBS, which represents a -1.7% decrease from the current price of $66.13.
The overall analyst consensus for NTR is bullish. Out of 6 Wall Street analysts, 16 rate it as Buy, 6 as Hold, and 2 as Sell, with a median price target of $82.50.
Stock price projections, including those for Nutrien Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.